Hans Deckmyn
Impact in
- Hematology top 0.1%
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Blood groups and transfusion
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
Papers in
- Hematology 180
- Platelet Disorders and Treatments 169
- Blood groups and transfusion 42
- Blood Coagulation and Thrombosis Mechanisms 29
-
- Cell Adhesion Molecules Research 36
- Co-authors
- Karen VanhoorelbekeJos VermylenSimon F. De MeyerPaolo GreseleHendrik B. FeysJ. VermylenKatleen BroosJef Arnout
- Journals
- Thrombosis and Haemostasis (62 papers)Blood (39 papers)Journal of Thrombosis and Haemostasis (20 papers)Journal of Biological Chemistry (12 papers)Thrombosis Research (11 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Hans Deckmyn
288 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Hematology 4.3k
- Internal Medicine 824
- Immunology and Allergy 939
- Cardiology and Cardiovascular Medicine 2.1k
- Immunology 1.9k
Countries citing papers authored by Hans Deckmyn
This map shows the geographic impact of Hans Deckmyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Deckmyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Deckmyn more than expected).
Fields of papers citing papers by Hans Deckmyn
This network shows the impact of papers produced by Hans Deckmyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Deckmyn. The network helps show where Hans Deckmyn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans Deckmyn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 104 | |
| 2 | 2020 | 30 | |
| 3 | 2019 | 2 | |
| 4 | 2016 | 130 | |
| 5 | Advances in a life-supporting xenogenic lung transplant model | 2013 | 0 |
| 6 | 2012 | 27 | |
| 7 | 2010 | 55 | |
| 8 | Thrombosis as an integral part of endovascular laser-tissue interactions | 2006 | 1 |
| 9 | Human ex-vivo, threshold u46619 induced platelet-aggregation is inhibited after bier block and epidural-anesthesia with xylocaine | 1993 | 4 |
| 10 | The antithrombotic effects of calin, a platelet-adhesion inhibitor from the medicinal leech, in a hamster femoral vein platelet-rich mural thrombosis model | 1993 | 1 |
| 11 | Pai-1 is not synthesized in human platelets | 1991 | 4 |
| 12 | Disturbed platelet-aggregation to collagen associated with an antibody against a 85-90 kda platelet glycoprotein in a patient with prolonged bleeding-time | 1991 | 4 |
| 13 | A murine monoclonal-antibody against vonwillebrand-factor (vwf) increases vwf binding to human platelet glycoprotein (gp) ib and gp iib/iiia | 1991 | 2 |
| 14 | A murine monoclonal-antibody against platelet glycoprotein iib iiia potently inhibits platelet functioning invitro and invivo | 1991 | 2 |
| 15 | R68070, a combined thromboxane synthase (tsi) and receptor blocker (tra), reduces thrombus formation in rats | 1989 | 3 |
| 16 | Synergistic effect of udcg212, a phosphodiesterase inhibitor (pde-i), and r68070, a combined thromboxane receptor antagonist (tra) and thromboxane synthase inhibitor (tsi), on platelet camp levels | 1989 | 2 |
| 17 | Influence of products of the cyclo-oxygenase pathway on platelet shape change | 1985 | 4 |
| 18 | The prostacyclin stimulating plasma factor (pspf) protects endothelial-cells from exhaustion | 1983 | 5 |
| 19 | Blood changes and enhanced thromboxane-b2 and 6-keto prostaglandin production in acute plasmodium-bergei infection in hamsters | 1983 | 2 |
| 20 | Dipyridamole inhibits platelet-aggregation in whole-blood invitro and exvivo | 1983 | 2 |
About Hans Deckmyn
Hans Deckmyn is a scholar working on Hematology, Immunology and Allergy, Internal Medicine, Immunology and Genetics, having authored 291 papers that have together received 9.8k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (169 papers), Antiplatelet Therapy and Cardiovascular Diseases (60 papers), Complement system in diseases (51 papers), Blood groups and transfusion (42 papers), Heparin-Induced Thrombocytopenia and Thrombosis (41 papers), Cell Adhesion Molecules Research (36 papers), Blood Coagulation and Thrombosis Mechanisms (29 papers) and Monoclonal and Polyclonal Antibodies Research (29 papers). The work is most often cited by research in Hematology (4.3k citations), Internal Medicine (824 citations), Immunology and Allergy (939 citations), Cardiology and Cardiovascular Medicine (2.1k citations) and Immunology (1.9k citations). Hans Deckmyn has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Karen Vanhoorelbeke, Jos Vermylen, Simon F. De Meyer, Paolo Gresele, Hendrik B. Feys, J. Vermylen, Katleen Broos, Jef Arnout, Philip W. Majerus and Jozef Arnout. Their work appears in journals such as Thrombosis and Haemostasis, Blood, Journal of Thrombosis and Haemostasis, Journal of Biological Chemistry and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.